Valuation: The Cooper Companies, Inc.

Capitalization 16.09B 13.7B 12.8B 12.04B 22.17B 1,457B 24.22B 149B 57.96B 687B 60.36B 59.09B 2,506B P/E ratio 2026 *
27x
P/E ratio 2027 * 22.8x
Enterprise value 17.86B 15.21B 14.21B 13.37B 24.62B 1,617B 26.89B 166B 64.34B 762B 67.01B 65.59B 2,782B EV / Sales 2026 *
4.14x
EV / Sales 2027 * 3.8x
Free-Float
91.2%
Yield 2026 *
0.01%
Yield 2027 * 0.01%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.04%
1 week+0.84%
Current month+5.33%
1 month+14.40%
3 months+23.10%
6 months+17.76%
Current year-10.71%
More quotes
1 week 77.64
Extreme 77.64
82.92
1 month 70.83
Extreme 70.83
89.83
Current year 61.78
Extreme 61.775
100.24
1 year 61.78
Extreme 61.775
100.24
3 years 61.78
Extreme 61.775
112.38
5 years 61.05
Extreme 61.0538
115.9
10 years 29.82
Extreme 29.82
115.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 55 2018-04-30
Director of Finance/CFO 46 2018-04-30
Chief Operating Officer 60 2013-10-31
Director TitleAgeSince
Director/Board Member 55 2018-04-30
Chairman 78 2021-03-22
Director/Board Member 62 2016-03-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.04%+0.84%-13.46%-0.46% 16.09B
-0.98%-6.77%+22.02%+53.57% 153B
-0.79%-4.43%-16.91%-6.04% 38.58B
0.00%-2.70% - - 7.78B
+10.00%-0.18%+300.87%+980.55% 3.39B
-0.86%-4.42%-21.68%-54.30% 1.89B
+0.02%-3.65%-8.03%+3.34% 1.14B
+2.30%+3.09%+6.52%-44.85% 761M
-0.52%-4.00%-19.10%-28.45% 717M
+0.36%-4.41%-31.88%-48.10% 381M
Average +0.95%-2.43%+24.26%+95.03% 22.34B
Weighted average by Cap. -0.66%-5.49%+15.96%+51.44%
See all sector performances

Financials

2026 *2027 *
Net sales 4.32B 3.68B 3.44B 3.23B 5.95B 391B 6.5B 40.1B 15.55B 184B 16.2B 15.86B 672B 4.55B 3.88B 3.62B 3.41B 6.27B 412B 6.85B 42.26B 16.39B 194B 17.07B 16.71B 709B
Net income 540M 460M 430M 404M 744M 48.91B 813M 5.02B 1.95B 23.06B 2.03B 1.98B 84.12B 660M 562M 525M 494M 909M 59.75B 993M 6.13B 2.38B 28.16B 2.48B 2.42B 103B
Net Debt 1.77B 1.51B 1.41B 1.33B 2.44B 161B 2.67B 16.46B 6.39B 75.67B 6.65B 6.51B 276B 1.22B 1.04B 972M 914M 1.68B 111B 1.84B 11.34B 4.4B 52.14B 4.58B 4.49B 190B
More financial data * Estimated data
Logo The Cooper Companies, Inc.
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Employees
15,000
More about the company
Date Price Change Volume
25-12-12 82.08 $ -0.04% 3,308,543
25-12-11 82.11 $ +1.70% 2,550,206
25-12-10 80.74 $ +2.84% 3,500,191
25-12-09 78.51 $ +0.61% 3,878,149
25-12-08 78.04 $ -4.13% 4,170,752

Delayed Quote Nasdaq, December 12, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
82.08USD
Average target price
90.50USD
Spread / Average Target
+10.26%
Consensus

Quarterly revenue - Rate of surprise